Patent 7247438 was granted and assigned to Dana-Farber Cancer Institute on July, 2007 by the United States Patent and Trademark Office.
Methods for identifying agents which enhance the activity of a caspase according to the invention are described, as well as methods for enhancing caspase activity and methods for enhancing apoptosis in a lymphocyte.